Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Diabetologia ; 58(10): 2414-23, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26099854

RESUMEN

AIMS/HYPOTHESIS: Ketogenic diets (KDs) have increasingly gained attention as effective means for weight loss and potential adjunctive treatment of cancer. The metabolic benefits of KDs are regularly ascribed to enhanced hepatic secretion of fibroblast growth factor 21 (FGF21) and its systemic effects on fatty-acid oxidation, energy expenditure (EE) and body weight. Ambiguous data from Fgf21-knockout animal strains and low FGF21 concentrations reported in humans with ketosis have nevertheless cast doubt regarding the endogenous function of FGF21. We here aimed to elucidate the causal role of FGF21 in mediating the therapeutic benefits of KDs on metabolism and cancer. METHODS: We established a dietary model of increased vs decreased FGF21 by feeding C57BL/6J mice with KDs, either depleted of protein or enriched with protein. We furthermore used wild-type and Fgf21-knockout mice that were subjected to the respective diets, and monitored energy and glucose homeostasis as well as tumour growth after transplantation of Lewis lung carcinoma cells. RESULTS: Hepatic and circulating, but not adipose tissue, FGF21 levels were profoundly increased by protein starvation, independent of the state of ketosis. We demonstrate that endogenous FGF21 is not essential for the maintenance of normoglycaemia upon protein and carbohydrate starvation and is therefore not needed for the effects of KDs on EE. Furthermore, the tumour-suppressing effects of KDs were independent of FGF21 and, rather, driven by concomitant protein and carbohydrate starvation. CONCLUSIONS/INTERPRETATION: Our data indicate that the multiple systemic effects of KD exposure in mice, previously ascribed to increased FGF21 secretion, are rather a consequence of protein malnutrition.


Asunto(s)
Dieta Cetogénica , Factores de Crecimiento de Fibroblastos/genética , Glucosa/metabolismo , Homeostasis/genética , Cetosis/genética , Neoplasias/genética , Deficiencia de Proteína/genética , Tejido Adiposo/metabolismo , Animales , Factores de Crecimiento de Fibroblastos/metabolismo , Cetosis/metabolismo , Hígado/metabolismo , Ratones , Ratones Noqueados , Neoplasias/dietoterapia , Neoplasias/metabolismo , Deficiencia de Proteína/metabolismo
3.
Sleep ; 29(9): 1233-8, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17040011

RESUMEN

STUDY OBJECTIVES: Sleep deprivation is a well-known paradigm to investigate the deleterious effects of prolonged wakefulness. Previous studies have shown that, during sleep deprivation, rats are hyperphagic but, paradoxically, lose body weight. This phenomenon has been attributed to increased metabolism. However, most previous studies have failed to account for food spillage, which may be considerable during sleep deprivation. DESIGN: In the present study, we revisited the issue of feeding changes in sleep-deprived rats and introduced different procedures to allow accurate estimation of food spillage prior to, during, and after 120 hours of sleep deprivation by a single platform technique. SETTING: Animal Sleep Research Laboratory, Psychobiology Department, Universidade Federal de São Paulo, Brazil. MEASUREMENTS AND RESULTS: The main finding was that, once corrected for spillage, food intake was not significantly increased during sleep deprivation. Increases in food removed from feeders were accompanied by proportional increases in food spillage, resulting in no net changes in food intake. Further, weight loss did occur during the sleep-deprivation period, especially in the first 24 hours, and it was actually explained by a reduction in food intake. CONCLUSION: The hyperphagia/weight-loss paradox previously seen during prolonged sleep deprivation does not necessarily occur with shorter periods of deprivation. Although we found no evidence of hyperphagia for up to 5 days of sleep deprivation in chow-fed rats, our data suggest that an impairment in the ability to increase food intake in response to increased energy expenditure contributes to the energy deficit during sleep deprivation in rats.


Asunto(s)
Hiperfagia/diagnóstico , Privación de Sueño/diagnóstico , Privación de Sueño/epidemiología , Pérdida de Peso , Animales , Conducta Animal , Ingestión de Energía , Conducta Alimentaria , Hiperfagia/epidemiología , Masculino , Ratas , Ratas Wistar
4.
Pharmacol Biochem Behav ; 81(4): 758-63, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16005949

RESUMEN

The present study was designed to investigate the effects of a hyperlipidic diet (HD) on penile erection (PE) and ejaculation (EJ) induced by cocaine in paradoxical sleep deprived (PSD) rats. Secondly, we aimed to verify the influence of HD cafeteria diet on steroid hormone levels. Twenty-one day-old male Wistar rats were randomly assigned into two groups: rats fed with commercial chow diet and rats fed with a palatable HD containing chow mixed with peanuts, milk chocolate and sweet cookies in the proportion of 3:2:2:1. After nine weeks of treatment, the animals were submitted to PSD or maintained as home cage control group for 96 h and challenged with cocaine (7 mg/kg, i.p.). Results showed that the HD led to a reduction in the frequency of erection in the PSD+cocaine group when compared to the PSD+cocaine fed with standard diet. Regardless of the diet, testosterone concentrations were significantly lower and progesterone was higher in the PSD rats than in the respective home-cage control rats. Although there were no hormonal alterations, the findings showed that a long-term HD might modify the stimulating effects of cocaine in potentiating genital reflexes in PSD rats.


Asunto(s)
Cocaína/farmacología , Grasas de la Dieta/administración & dosificación , Eyaculación/efectos de los fármacos , Erección Peniana/efectos de los fármacos , Privación de Sueño/fisiopatología , Análisis de Varianza , Animales , Eyaculación/fisiología , Masculino , Erección Peniana/fisiología , Progesterona/sangre , Ratas , Ratas Wistar , Reflejo/efectos de los fármacos , Privación de Sueño/sangre , Sueño REM/fisiología , Testosterona/sangre , Vasoconstrictores/farmacología
5.
Regul Pept ; 117(3): 155-8, 2004 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-14749034

RESUMEN

The hypocretins (orexins) are recently discovered neuropeptides initially associated with feeding behavior and sleep regulation. However, the normal function of these peptides is unclear and a number of studies have reported a role in energy homeostasis and locomotor activity. Exercise (or physical activity) is the most powerful way of challenging the internal homeostatic process. This study examines the circadian differences in response to forced activity and homeostatic challenges on hypocretin-1 (Hcrt-1) levels in the cerebrospinal fluid (CSF) of rats. Hcrt-1 levels were decreased after long-term immobilization at the end of active phase (zeigeber time-0, ZT-0) and increased after short-term forced swimming in the rest phase (ZT-8). Nevertheless, no effects were observed after short-term immobilization, total sleep deprivation or cold exposure. We concluded that despite the relation between hypocretins, stress and sleep regulation reported in the literature, short-term total sleep deprivation, immobilization and cold exposure did not induce increases in CSF Hcrt-1 levels at ZT-0 and ZT-8. On the other hand, the relationship between hypocretinergic system activation and motor activation is reinforced by decrease in Hcr-1 levels after long-term immobilization at ZT-0 and its increased levels after short-term forced swimming at ZT-8 in CSF of rats.


Asunto(s)
Proteínas Portadoras/líquido cefalorraquídeo , Péptidos y Proteínas de Señalización Intracelular , Neuropéptidos/líquido cefalorraquídeo , Natación/fisiología , Animales , Masculino , Orexinas , Ratas , Ratas Wistar , Privación de Sueño , Regulación hacia Arriba
6.
Brain Res ; 995(1): 1-6, 2004 Jan 02.
Artículo en Inglés | MEDLINE | ID: mdl-14644464

RESUMEN

Rat cisternal (CSF) hypocretin-1 in cerebrospinal fluid was measured after 6 or 96 h of REM sleep deprivation and following 24 h of REM sleep rebound. REM deprivation was found to increase CSF hypocretin-1 collected at zeitgeber time (ZT) 8 but not ZT0. Decreased CSF hypocretin levels were also observed at ZT8 after 24 h of REM sleep rebound. These results suggest that REM sleep deprivation activates and REM sleep rebound inhibits the hypocretin system. Increased hypocretin tone during REM deprivation may be important in mediating some of the effects of REM sleep deprivation such as antidepressant effects, hyperphagia and increased sympathetic activity.


Asunto(s)
Proteínas Portadoras/líquido cefalorraquídeo , Ritmo Circadiano/fisiología , Péptidos y Proteínas de Señalización Intracelular , Neuropéptidos/líquido cefalorraquídeo , Privación de Sueño/líquido cefalorraquídeo , Sueño REM/fisiología , Animales , Hipotálamo/metabolismo , Masculino , Actividad Motora/fisiología , Orexinas , Ratas , Ratas Wistar , Regulación hacia Arriba/fisiología , Vigilia/fisiología
7.
Obesity (Silver Spring) ; 19(2): 380-7, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21030948

RESUMEN

Roux-en-y gastric bypass (RYGB) surgery rapidly improves glucose tolerance and reverses insulin resistance in obese patients. It has been hypothesized that this effect is mediated by the diversion of nutrients from the proximal small intestine. We utilized duodenal-jejunal bypass (DJB) as a modification of gastric bypass to determine the effect of nutrient diversion from the foregut without gastric restriction on insulin resistance in obese rats. The effects of DJB or Sham surgery on glucose homeostasis were determined in both high-fat-fed Long-Evans and Wistar rats. Body weight and food intake were measured weekly postoperatively, and body composition was monitored before and after surgery. Glucose tolerance was tested before and as early as 1 month postoperation; additionally, in Wistar rats, insulin sensitivity was determined by a hyperinsulinemic-euglycemic clamp (HIEC). DJB did not affect body weight, body composition, glucose tolerance, or insulin concentrations over the period of the study. The average glucose infusion rate (GIR) during the HIEC was 6.2 ± 1.16 mg/kg/min for Sham rats compared to 7.2 ± 1.71 mg/kg/min for DJB rats (P = 0.62), and neither endogenous glucose production (EGP; P = 0.81) nor glucose utilization (glucose disappearance (R(d)), P = 0.59) differed between DJB and Sham rats. DJB does not affect insulin resistance induced by a high-fat diet in Long-Evans and Wistar rats. These data suggest that duodenal bypass alone is an insufficient mechanism to alter insulin sensitivity independent of weight loss in obese, nondiabetic rodents.


Asunto(s)
Glucemia/metabolismo , Duodeno/cirugía , Resistencia a la Insulina , Yeyuno/cirugía , Obesidad/cirugía , Animales , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/fisiopatología , Modelos Animales de Enfermedad , Derivación Gástrica , Técnica de Clampeo de la Glucosa , Prueba de Tolerancia a la Glucosa , Insulina/metabolismo , Masculino , Obesidad/metabolismo , Ratas , Ratas Long-Evans , Ratas Wistar
8.
Diabetes ; 59(10): 2418-25, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20682682

RESUMEN

OBJECTIVE: Olanzapine (OLZ) is an atypical antipsychotic whose clinical efficacy is hampered by side effects including weight gain and diabetes. Recent evidence shows that OLZ alters insulin sensitivity independent of changes in body weight and composition. The present study addresses whether OLZ-induced insulin resistance is driven by its central actions. RESEARCH DESIGN AND METHODS: Sprague-Dawley rats received an intravenous (OLZ-IV group) or intracerebroventricular (OLZ-ICV group) infusion of OLZ or vehicle. Glucose kinetics were assessed before (basal period) and during euglycemic-hyperinsulinemic clamp studies. RESULTS: OLZ-IV caused a transient increase in glycemia and a higher rate of glucose appearance (R(a)) in the basal period. During the hyperinsulinemic clamp, the glucose infusion rate (GIR) required to maintain euglycemia and the rate of glucose utilization (R(d)) were decreased in OLZ-IV, whereas endogenous glucose production (EGP) rate was increased compared with vehicle-IV. Consistent with an elevation in EGP, the OLZ-IV group had higher hepatic mRNA levels for the enzymes glucose-6-phosphatase and phosphoenolpyruvate carboxykinase. Phosphorylation of hypothalamic AMP-activated protein kinase (AMPK) was increased in OLZ-IV rats compared with controls. Similarly, an intracerebroventricular infusion of OLZ resulted in a transient increase in glycemia as well as a higher R(a) in the basal period. During the hyperinsulinemic period, OLZ-ICV caused a decreased GIR, an increased EGP, but no change in R(d). Furthermore, OLZ-ICV rats had increased hepatic gluconeogenic enzymes and elevated hypothalamic neuropeptide-Y and agouti-related protein mRNA levels. CONCLUSIONS: Acute central nervous system exposure to OLZ induces hypothalamic AMPK and hepatic insulin resistance, pointing to a hypothalamic site of action for the metabolic dysregulation of atypical antipsychotics.


Asunto(s)
Antipsicóticos/farmacología , Benzodiazepinas/farmacología , Resistencia a la Insulina/fisiología , Hígado/fisiología , Animales , Antipsicóticos/administración & dosificación , Benzodiazepinas/administración & dosificación , Glucemia/efectos de los fármacos , Glucemia/metabolismo , Arterias Carótidas/fisiopatología , Cartilla de ADN , Técnica de Clampeo de la Glucosa , Glucosa-6-Fosfatasa/efectos de los fármacos , Glucosa-6-Fosfatasa/genética , Hiperinsulinismo/fisiopatología , Infusiones Intravenosas , Inyecciones Intraventriculares , Péptidos y Proteínas de Señalización Intracelular/efectos de los fármacos , Péptidos y Proteínas de Señalización Intracelular/genética , Venas Yugulares/fisiopatología , Cinética , Hígado/efectos de los fármacos , Masculino , Neuropéptidos/efectos de los fármacos , Neuropéptidos/genética , Olanzapina , Orexinas , Proopiomelanocortina/efectos de los fármacos , Proopiomelanocortina/genética , Ratas , Ratas Sprague-Dawley , Tubulina (Proteína)/efectos de los fármacos , Tubulina (Proteína)/genética
9.
Eur J Pain ; 14(10): 985-91, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20400347

RESUMEN

This study aims to evaluate the impact of neonatal arthritis on adult pain threshold, sleep and general behaviours in rats and their lactating dams. Male pups were injected in the hind paw with complete Freund's adjuvant or saline on postnatal day (PN) 1. After weaning, dams were tested for anxiety, sleep recording or hormone profiling (ACTH, corticosterone and prolactin) and brain sampling (pineal melatonin and hippocampus serotonin). At adulthood (PN90), distinct subgroups of neonatal arthritic (AR) and control rats (CR) were also assessed for anxiety and pain thresholds, sleep recording, and blood/brain sampling. Compared to their respective controls at PN12, dams of arthritic rats (DAR) showed a longer latency in expressing pup retrieval and dam-pup interaction. DAR and AR showed a lower pain threshold, anxiety-like behaviour, and sleep fragmentation. Compared to controls, DAR displayed longer sleep latency, reduced paradoxical sleep latency and sleep efficiency, a decrease in prolactin and serotonin levels and increased melatonin levels. This model of unilateral hindpaw inflammation has a wide range of long-term effects in both lactating dams and their adult offspring.


Asunto(s)
Artritis Experimental/psicología , Conducta Animal/fisiología , Trastornos del Sueño-Vigilia/etiología , Animales , Animales Recién Nacidos , Antígenos Bacterianos , Ansiedad/psicología , Química Encefálica/efectos de los fármacos , Electrodos Implantados , Femenino , Adyuvante de Freund , Hormonas/sangre , Calor , Rayos Láser , Masculino , Melatonina/metabolismo , Mycobacterium , Umbral del Dolor/efectos de los fármacos , Embarazo , Ratas , Ratas Wistar , Tiempo de Reacción/fisiología , Serotonina/metabolismo , Trastornos del Sueño-Vigilia/psicología
10.
J Sleep Res ; 14(1): 83-90, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15743338

RESUMEN

Since previous data of our group showed increased concentrations in HPA axis hormones in sleep deprived rats, we hypothesized that this augmentation could produce effects in other hormonal systems, particularly in the sexual system. Considering that little is known about how the hormonal system changes during the recovery period after sleep deprivation (SD), our objective was to examine from what point SD alters sexual and stress-related hormones along with plasma catecholamine concentrations during 4 days. We also sought to verify the time course of their recovery after an equivalent period of recovery sleep. Rats were deprived of sleep by the platform technique for 1-4 days and were allowed to recover for the same period. Plasma catecholamines [dopamine (DA) and noradrenaline (NOR)], testosterone, estrone, progesterone, prolactin, corticosterone and adrenocorticotropic hormone (ACTH) concentrations were measured. Comparisons between groups showed that the SD procedure used in the present study produced marked alterations in almost all studied hormones from 24 h of SD, except for estrone and prolactin (which required 96 h of SD to become altered). Testosterone and estrone decreased, whereas progesterone, prolactin, corticosterone, ACTH, DA and NOR increased. During recovery period, progesterone, prolactin and corticosterone concentrations returned to control levels, whereas testosterone, estrone, NOR and DA did not. In addition, after 48 h of recovery ACTH and NOR decreased below control concentrations, remaining low until 96 h of sleep recovery. Thus, SD showed long lasting, differential effects upon these neurochemicals suggesting that each has its own pattern of responses to SD as well as variable periods of recovery.


Asunto(s)
Catecolaminas/metabolismo , Corticosterona/metabolismo , Prolactina/metabolismo , Recuperación de la Función , Privación de Sueño/metabolismo , Privación de Sueño/fisiopatología , Testosterona/metabolismo , Hormona Adrenocorticotrópica/metabolismo , Animales , Sistema Hipotálamo-Hipofisario/metabolismo , Masculino , Sistema Hipófiso-Suprarrenal/metabolismo , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA